Vasopeptidase inhibition: A new concept in blood pressure management

Medicine & Life Sciences

• omapatrilat 100%
• Vasopeptidase Inhibitors 42%
• Blood Pressure 35%
• Peptidyl-Dipeptidase A 34%
• Antihypertensive Agents 21%
• Natriuretic Peptides 19%
• Animal Models 17%
• C-Type Natriuretic Peptide 11%
• Heart Failure 11%
• Adrenomedullin 10%
• Neprilysin 10%
• Dipeptides 10%
• Peptides 10%
• Ventricular Remodeling 9%
• Bradykinin 8%
• Atrial Natriuretic Factor 8%
• Brain Natriuretic Peptide 8%
• Inbred SHR Rats 8%
• Essential Hypertension 8%
• Renin-Angiotensin System 8%
• Vasoconstriction 8%
• Vasodilator Agents 8%
• Renin 8%
• Angiotensin-Converting Enzyme Inhibitors 7%
• Vasodilation 7%
• Half-Life 7%
• Endothelial Cells 5%
• Clinical Trials 5%
• Hypertension 5%
• Morbidity 4%
• Blood Vessels 4%
• Survival 4%
• Enzymes 4%
• Mortality 4%
• Therapeutics 2%